Pembrolizumab
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Masahiro Tsuboi
Overview
Pembrolizumab is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Pembrolizumab clinical trials
Explore related
Medical disclaimer. This page summarizes research about Pembrolizumab for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.